(MENAFN- PR Newswire)
North America will account for 45 percent of market growth. In North America, the primary markets for renal anemia medicines are the United States and Canada. The market in this region will grow more slowly than the market in Asia.
Renal anemia treatments market expansion in North America would be aided by the rising prevalence of kidney illness in the United States over the forecast period.
Download Sample Report : to know additional highlights and key points on various market segments and their impact in coming years.
Imperative Insights on the following aspects:
- What was the size of the global renal anemia therapeutics industry by value in 2020?
- What will be the size of the global renal anemia therapeutics industry in 2026?
- What factors are affecting the strength of competition in the global renal anemia therapeutics industry?
- How has the industry performed over the last five years?
- What are the main segments that make up the global renal anemia therapeutics market?
Do reach out to our analysts for more customized reports as per your requirements. Speak to our Analyst now!
The renal anemia therapeutics market research report presents critical information and factual data about the renal anemia therapeutics industry, with an overall statistical study of this market based on market drivers, market limitations, and its future prospects. The widespread trends and opportunities are also taken into consideration in the renal anemia therapeutics market study.
Why buy?
- Identify growth Strategies across markets
- Refine your business plan & growth
- Assess the financial performance of competitors.
Purchase Renal Anemia Therapeutics Market report, Download Sample Report Now!
Related Reports:
Vaccines Market by Type and Geography - Forecast and Analysis 2022-2026
Global Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2022-2026
| Renal Anemia Therapeutics Market Scope |
| Report Coverage | Details |
| Page number | 120 |
| Base year | 2021 |
| Forecast period | 2022-2026 |
| Growth momentum & CAGR | Accelerate at a CAGR of 8.25% |
| Market growth 2022-2026 | $ 1.97 billion |
| Market structure | Fragmented |
| YoY growth (%) | 7.65 |
| Regional analysis | North America, Europe, Asia, and Rest of World (ROW) |
| Performing market contribution | North America at 45% |
| Key consumer countries | US, Canada, Germany, UK, and China |
| Competitive landscape | Leading companies, Competitive strategies, Consumer engagement scope |
| Key companies profiled | AstraZeneca Plc, Akebia Therapeutics Inc., Amgen Inc., Bayer AG, Covis Pharma BV, Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., FibroGen Inc., GlaxoSmithKline Plc, JCR Pharmaceticals Co. Ltd., JSC BIOCAD, Pfizer Inc., and Pharmacosmos AS |
| Market dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Content:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
- 5.1 Market segments
- Exhibit 24: Chart on Application - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
- 5.2 Comparison by Application
- Exhibit 26: Chart on Comparison by Application
- Exhibit 27: Data Table on Comparison by Application
- 5.3 IV - Market size and forecast 2021-2026
- Exhibit 28: Chart on IV - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on IV - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on IV - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on IV - Year-over-year growth 2021-2026 (%)
- 5.4 Oral - Market size and forecast 2021-2026
- Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Application
- Exhibit 36: Market opportunity by Application ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 AstraZeneca Plc
- Exhibit 85: AstraZeneca Plc - Overview
- Exhibit 86: AstraZeneca Plc - Product / Service
- Exhibit 87: AstraZeneca Plc - Key news
- Exhibit 88: AstraZeneca Plc - Key offerings
- 10.4 Akebia Therapeutics Inc.
- Exhibit 89: Akebia Therapeutics Inc. - Overview
- Exhibit 90: Akebia Therapeutics Inc. - Product / Service
- Exhibit 91: Akebia Therapeutics Inc. - Key offerings
- 10.5 Amgen Inc.
- Exhibit 92: Amgen Inc. - Overview
- Exhibit 93: Amgen Inc. - Product / Service
- Exhibit 94: Amgen Inc. - Key offerings
- 10.6 Bayer AG
- Exhibit 95: Bayer AG - Overview
- Exhibit 96: Bayer AG - Business segments
- Exhibit 97: Bayer AG - Key offerings
- Exhibit 98: Bayer AG - Segment focus
- 10.7 Covis Pharma BV
- Exhibit 99: Covis Pharma BV - Overview
- Exhibit 100: Covis Pharma BV - Product / Service
- Exhibit 101: Covis Pharma BV - Key offerings
- 10.8 Daiichi Sankyo Co. Ltd.
- Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
- Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
- Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
- Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
- Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
- 10.9 Dr. Reddys Laboratories Ltd.
- Exhibit 107: Dr. Reddys Laboratories Ltd. - Overview
- Exhibit 108: Dr. Reddys Laboratories Ltd. - Business segments
- Exhibit 109: Dr. Reddys Laboratories Ltd. - Key offerings
- Exhibit 110: Dr. Reddys Laboratories Ltd. - Segment focus
- 10.10 GlaxoSmithKline Plc
- Exhibit 111: GlaxoSmithKline Plc - Overview
- Exhibit 112: GlaxoSmithKline Plc - Business segments
- Exhibit 113: GlaxoSmithKline Plc - Key news
- Exhibit 114: GlaxoSmithKline Plc - Key offerings
- Exhibit 115: GlaxoSmithKline Plc - Segment focus
- 10.11 JSC BIOCAD
- Exhibit 116: JSC BIOCAD - Overview
- Exhibit 117: JSC BIOCAD - Product / Service
- Exhibit 118: JSC BIOCAD - Key offerings
- 10.12 Pharmacosmos AS
- Exhibit 119: Pharmacosmos AS - Overview
- Exhibit 120: Pharmacosmos AS - Product / Service
- Exhibit 121: Pharmacosmos AS - Key offerings
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 122: Inclusions checklist
- Exhibit 123: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 124: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 125: Research methodology
- Exhibit 126: Validation techniques employed for market sizing
- Exhibit 127: Information sources
- 11.5 List of abbreviations
- Exhibit 128: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact Us:
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [email protected] Website:
SOURCE Technavio
MENAFN18052022003732001241ID1104235023
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.